Gullans Steven R. Ph.D.
Insider CIK 1571997 · TTPH Director, 10% owner · ALRN 10% owner · ISPC Director · GEMP President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ISPC iSpecimen Inc. | A Award deriv | 2024-01-02 | 2024-05-20 | 10,000 | $0.53 | $5.3K | 33,525 | SEC↗ |
| ISPC iSpecimen Inc. | A Award deriv | 2023-01-03 | 2023-01-13 | 10,000 | $1.41 | $14.1K | 23,525 | SEC↗ |
| ISPC iSpecimen Inc. | A Award | 2023-01-01 | 2023-05-17 | 125 | — | $0 | 3,250 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award deriv | 2020-01-13 | 2020-01-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award | 2019-07-24 | 2019-07-26 | 300,000 | — | $0 | 300,000 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2018-05-22 | 2018-05-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2018-05-22 | 2018-05-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2018-05-01 | 2018-05-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy | 2018-02-08 | 2018-02-12 | 71,429 | $7.00 | $500.0K | 930,252 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2018-01-29 | 2018-01-30 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 1,329,993 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 5,934,050 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 1,153,606 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 1,083,119 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | P Buy | 2017-07-05 | 2017-07-06 | 60,000 | $15.00 | $900.0K | 1,016,100 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion | 2017-07-05 | 2017-07-06 | 956,100 | — | $0 | 956,100 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2017-05-30 | 2017-05-31 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy deriv | 2017-03-10 | 2017-03-14 | 39,599 | $9.47 | $375.0K | 39,599 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy | 2017-03-10 | 2017-03-14 | 52,798 | $9.47 | $500.0K | 858,823 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion deriv | 2016-08-10 | 2016-08-12 | 0 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy | 2016-08-10 | 2016-08-12 | 500,000 | $10.00 | $5.00M | 806,025 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion | 2016-08-10 | 2016-08-12 | 306,025 | $6.71 | $2.05M | 306,025 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2016-08-04 | 2016-08-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2014-06-12 | 2014-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2014-05-19 | 2014-05-21 | 25,000 | $9.24 | $231.0K | 25,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2013-03-25 | 2013-03-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 28,199,144 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 972,384 | — | $0 | 972,384 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 496,121 | $7.00 | $3.47M | 1,468,505 | SEC↗ |